Methicillin-susceptible staphylococcus aureus infections are caused by gram-positive bacterium, which leads to skin allergies, pneumonia and endocarditis.
This report contains market size and forecasts of Methicillin-Susceptible Staphylococcus Aureus in Global, including the following market information:
Global Methicillin-Susceptible Staphylococcus Aureus Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Methicillin-Susceptible Staphylococcus Aureus market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Cephalosporins Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Methicillin-Susceptible Staphylococcus Aureus include Dainippon Sumitomo Pharma Co., Ltd, Immtech Pharmaceuticals, Inc., Lytix Biopharma AS, PharmaIN Corporation, Cubist Pharmaceuticals, Kenta Biotech AG, Arsanis Biosciences GmbH, Volcano Corporation and Abbott Laboratories and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Methicillin-Susceptible Staphylococcus Aureus companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Methicillin-Susceptible Staphylococcus Aureus Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Methicillin-Susceptible Staphylococcus Aureus Market Segment Percentages, by Type, 2021 (%)
Cephalosporins
Vancomycin
Linezolid
Others
Global Methicillin-Susceptible Staphylococcus Aureus Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Methicillin-Susceptible Staphylococcus Aureus Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Others
Global Methicillin-Susceptible Staphylococcus Aureus Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Methicillin-Susceptible Staphylococcus Aureus Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Methicillin-Susceptible Staphylococcus Aureus revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Methicillin-Susceptible Staphylococcus Aureus revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Dainippon Sumitomo Pharma Co., Ltd
Immtech Pharmaceuticals, Inc.
Lytix Biopharma AS
PharmaIN Corporation
Cubist Pharmaceuticals
Kenta Biotech AG
Arsanis Biosciences GmbH
Volcano Corporation
Abbott Laboratories
AngioScore Inc.